medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2020, Number 01

<< Back Next >>

Ginecol Obstet Mex 2020; 88 (01)

Goals of prepartum treatment of preeclamptic patients in the intensive care unit

Vázquez-Rodríguez JG, Herrera-Escobedo I

Language: Spanish
References: 20
Page: 14-22
PDF size: 222.98 Kb.


ABSTRACT

Objective: To know the percentage of goals achieved from the prepartum treatment of preeclamptic pregnant patients in the Intensive Care Unit (ICU).
Materials and Methods: A cross-sectional study included 100 preeclamptic pregnant patients admitted to the ICU of a high-specialty hospital in Mexico City. Values before and after intensive treatment (baseline and antepartum measurement) were compared considering nine goals: 1) mean arterial pressure ≤95 mmHg 2) central venous pressure 6 to 10 cm water, 3) diuresis 1.5 to 2 mL/K weight/hour, 4) blood glucose ‹160 mg / dL, 5) plasma colloid osmotic pressure 24 ± 2 mmHg, 6) pH arterial blood 7.37 to 7.44, 7) hemoglobin 10 to 14 g / dL, 8) platelet count ≥100,000 platelets / µL and 9) absent seizures. It was considered as a goal met when the antepartum measurement was in the desired range and goal not met when it was different. Statistical analysis: descriptive statistics and Student's t-test.
Results: Goals met absent seizures 100%, blood glucose 93%, platelet count 86%, hemoglobin 74%, mean blood pressure 39%, diuresis 36%, pH arterial blood 30%, central venous pressure 24% and plasma colloid osmotic pressure 11%. The overall average was 54.77%.
Conclusions: the goals with percentage of compliance ≥70% were seizures, blood glucose, platelet count and hemoglobin. The goals with compliance ‹70% were mean blood pressure, diuresis, pH arterial blood, central venous pressure and plasma colloid osmotic pressure. The evaluation by goals allows to identify the strengths and weaknesses of the treatment of preeclampsia in the ICU.


REFERENCES

  1. Phyllis A, Sibai B. Preeclampsia: clinical features and diagnosis. UpToDate. July, 2015. Dirección http://www. uptodate.com/contents/clinical-features-and-diagnosis.

  2. ACOG Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia. Obstet Gynecol 2019; 133: e1-e25. doi: 10.1097/AOG.0000000000003018

  3. Shah AK, et al. Eclampsia: a neurological perspective. J Neurol Sci 2008; 271: 158-167. 10.1016/j.jns.2008.04.010

  4. Weinstein L. Syndrome of hemolysis, elevated liver enzymes and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982; 142: 159-67. https://doi.org/10.1016/j.ajog.2005.02.113

  5. WHO Recommendations for Prevention and Treatment of Pre-eclampsia and Eclampsia. Switzerland. WHO Library Cataloguing-in-Publication Data. 2011. http://whqlibdoc. who.int/publications/2011/9789241548335_eng.pdf

  6. Magee LA, et al. On behalf of the Canadian hypertensive disorders of pregnancy (HDP) working group. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. Pregnancy Hypertension 2014; 4: 105-45. http://dx.doi.org/10.1016/j.preghy.2014.01.003

  7. Royal College of Obstetricians and Gynaecologists. Hypertension in pregnancy: diagnosis and management. NICE guideline [NG133]. London UK. National Institute for Health and Clinical Excellence NICE. Published date: June 2019. https://www.nice.org.uk/guidance/ng133.

  8. Prevención, diagnóstico y manejo de la preeclampsiaeclampsia. Lineamiento técnico. México. Centro Nacional de Equidad de Género y Salud Reproductiva de la Secretaría de Salud. 2007. http://www.salud.gob.mx/unidades/cdi/ documentos/PREECLAMPSIA_ECLAMPSIA_lin-2007.pdf.

  9. Detección y diagnóstico de enfermedades hipertensivas del embarazo. México. Secretaría de salud. 2010. http:// www.cenetec.salud.gob.mx/interior/gpc.htmL. (Consulta: septiembre 2019)

  10. Guía de Práctica Clínica. Actualización 2017. Prevención, Diagnóstico y Tratamiento de la preeclampsia en el segundo y tercer nivel de atención. México. Secretaría de Salud. 2017. Dirección URL: http://www.cenetec.salud.gob.mx/ contenidos/gpc/catalogoMaestroGPC.htmL. (Consulta: septiembre 2019)

  11. Willatts SM. Development of intensive therapy. Intensive Care Medicine 1990, 16:474-476. https://doi.org/10.1007/ BF01711235

  12. Lapinsky SE, Kruczynski K, Slutsky A. Critical care in the pregnant patient. Crit Care Med 1995;152:427-55. doi: 10.1164/ajrccm.152.2.7633692

  13. Consejo Nacional de Evaluación de la Política de Desarrollo Social. Evaluación estratégica sobre mortalidad materna en México 2010: características sociodemográficas que obstaculizan a las mujeres embarazadas su acceso efectivo a instituciones de salud. México, DF: CONEVAL, 2012. https://www.coneval.org.mx/Informes/Evaluacion/ Mortalidad%20materna%202010/INFORME_MORTALIDAD_ MATERNA.pdf

  14. Organización Mundial de la Salud. Mortalidad materna. Nota descriptiva. 16 de febrero del 2018. https://www. who.int/es/news-room/fact-sheets/detail/maternalmortality.

  15. Vázquez-Rodríguez JG. Control de la tensión arterial media y su correlación con la función renal en pacientes con preeclampsia severa tratadas con tres agentes antihipertensivos orales. Ginecol Obstet Mex 2009; 77: 219-26. https://www.medigraphic.com/pdfs/ginobsmex/ gom-2009/gom095c.pdf

  16. Olaya-Garay SX, et al. Blood pressure in adolescent patients with pre-eclampsia and eclampsia. Int J Ginecol Obstet 2017; 138: 335-39. doi:10.1002/ijgo.12237

  17. Bouvier-Colle MH, et. al. Obstetrics patients treated in intensive care units and maternal mortality. Eur J Obstet Gynecol Reprod Biol 1996; 65:121-25. https://www.ejog. org/article/0028-2243(95)02317-L/pdf

  18. Vázquez-Rodríguez JG, Becerril-Serrano A. Líquidos cristaloides sobre la glucemia en preeclampsia severa. Rev Med Inst Mex Seguro Soc 2012; 50: 183-88. Dirección URL: https://www.medigraphic.com/pdfs/imss/im-2012/ im122l.pdf (Consulta: septiembre 2019)

  19. Curiel-Balsera E, Prieto-Palomino MA, Muñoz-Bono J, Ruiz de Elvira MJ, Galeas JL, Quesada García G. Analysis of maternal morbidity and mortality among patients admitted to obstetric intensive care with severe preeclampsia, eclampsia or HELLP syndrome. Med Intensiva 2011;35:478- 483. Dirección URL: http://www.medintensiva.org/en-pdf- S2173572711000518 (Consulta: septiembre 2019).

  20. Lo JO, Mission JF, Caughey AB. Hypertensive disease of pregnancy and maternal mortality. Curr Opin Obstet Gynecol 2013;25(2):124-132. DOI: 10.1097/ GCO.0b013e32835e0ef5




2020     |     www.medigraphic.com